Gilead Sciences Inc (GILD)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 22,498,000 22,065,000 21,579,000 21,331,000 21,148,000 21,586,000 21,748,000 21,409,000 21,624,000 20,248,000 20,799,000 20,808,000 20,704,000 22,110,000 21,348,000 20,600,000 20,117,000 18,290,000 17,423,000 18,029,000
Revenue (ttm) US$ in thousands 28,749,000 28,295,000 27,800,000 27,450,000 27,116,000 27,390,000 27,382,000 27,043,000 27,281,000 27,136,000 27,515,000 27,472,000 27,305,000 27,482,000 26,638,000 25,564,000 24,689,000 23,147,000 22,174,000 22,716,000
Gross profit margin 78.26% 77.98% 77.62% 77.71% 77.99% 78.81% 79.42% 79.17% 79.26% 74.62% 75.59% 75.74% 75.82% 80.45% 80.14% 80.58% 81.48% 79.02% 78.57% 79.37%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $22,498,000K ÷ $28,749,000K
= 78.26%

Gilead Sciences Inc's gross profit margin has shown fluctuations over the past few years based on the provided data. The gross profit margin indicates the percentage of revenue that exceeds the cost of goods sold, reflecting the efficiency of the company's production process and pricing strategy.

From March 2020 to June 2021, the gross profit margin remained relatively stable, ranging between 78.57% and 81.48%. This stability demonstrates consistent control over production costs and pricing during this period.

However, from December 2021 to September 2022, there was a decline in the gross profit margin, with a downward trend from 81.48% to 74.62%. This decrease could be attributed to various factors such as increased production costs, changes in product pricing, or shifts in market dynamics impacting profitability.

Subsequently, from December 2022 to December 2024, the gross profit margin showed a slight recovery, fluctuating between 77.62% and 78.26%. This improvement suggests potential cost management initiatives or strategic pricing adjustments that positively impacted the company's profitability during this period.

Overall, Gilead Sciences Inc's gross profit margin fluctuated over the analyzed period, indicating the company's ability to manage production costs and pricing strategies in response to internal and external factors influencing its financial performance. It would be important for stakeholders to monitor these trends and assess the company's operational efficiency and profitability in the future.


See also:

Gilead Sciences Inc Gross Profit Margin (Quarterly Data)